Home > Information
Information
- Dec. 16, 2024
- Professor Chappell, UK's Department of Health and Social Care visited
- Dec. 16, 2024
- Korea University Medicine Delegation visited
- Dec. 12, 2024
- Launch of "TMC Japan BioBridge / JACT Program"
- Nov. 22, 2024
- Three Researchers from National Cancer Center on ‘Highly Cited Researchers 2024’ List
- Nov. 5, 2024
- NCC will initiate new research to develop a nationwide Clinical Trial Network, LC-SCRUM-CD (Clinical Development), supported by PREMIA and Paradigm, to further accelerate precision medicine for cancer patients.
- Sep. 20, 2024
- HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval
- Sep. 17, 2024
- SCRUM-Japan GOZILA Confirms Extended Survival with Personalized Cancer Treatment in 4,000+ Patients Study
- Sep. 17, 2024
- CIRCULATE-Japan GALAXY Confirms Effectiveness of Liquid Biopsy in Predicting Recurrence Risk and Post-operative Treatment Efficacy in Colorectal Cancer
- Sep. 12, 2024
- Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
- Aug. 9, 2024
- Start of Fecal Microbiota Transplantation Clinical Study for Esophageal and Gastric Cancer Patients
- Aug. 6, 2024
- Visit to National Cancer Institute
- Aug. 1, 2024
- Philippine Health Secretary’s Delegation Visited Tsukiji
- Jul. 11, 2024
- Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
- Jun. 11, 2024
- Collaborative Research for Advanced Data Linkage between Electronic Medical Records and Clinical Trial Data Collection System
- Jun. 10, 2024
- Dutch-Japanese workshop 'AI for Health' held
- Jun. 10, 2024
- Dr Tatsuhiro Shibata nominated Scientific Council Member of IARC
- Jun. 4, 2024
- NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
- May 14, 2024
- World’s Largest Whole Genome Sequencing of Renal Cancer:
mutational signature linked to an unknown exposure discovered in 70% of Japanese samples - May 8, 2024
- Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure
- Apr. 4, 2024
- Delegation from Republic of Lithuania visited
- Apr. 2, 2024
- Leadership from the Taipei Economic and Cultural Representative Office (TECRO) in Japan visited
- Mar. 19, 2024
- National Health Commission of the PRC visited
- Mar. 14, 2024
- MoU signing ceremony with National Cancer Institute, Thailand
- Mar. 8, 2024
- WHO Regional Director for Western Pacific visited
- Jan. 15, 2024
- Result of a Japan-led International Investigator-Initiated Registration-Directed Trial Offers a New Treatment Option of Palbociclib in Combination with Tamoxifen
- Jan. 12, 2024
- Team explores role of STING – stimulator of interferon genes – in body’s innate immune system
- Jan. 11, 2024
- An Asian Multicenter Clinical Trial Evaluating Efficacy of
Computer-Aided Detection for Colonoscopy in Colorectal Cancer Screening